Clinical Roundup Study: Advanced multi-omics platform predicts superior OS and DFS for in glioblastoma June 11, 2021Vol.47 No.23
Clinical RoundupFree Lynparza in the adjuvant treatment of patients with germline BRCA1/2 mutations and high-risk early breast cancer reduced the risk of cancer recurrence by 42% in OlympiA phase III trial June 04, 2021Vol.47 No.22
Clinical RoundupFree Choice of first-line platinum regimen does not significantly impact efficacy of second-line immunotherapy in advanced bladder cancer June 04, 2021Vol.47 No.22
Clinical RoundupFree Survey: Cancer patients and survivors continue to face pandemic-related health care delays one year later June 04, 2021Vol.47 No.22
Clinical RoundupFree Dual immunotherapy regimen delays cancer progression in patients with advanced melanoma June 04, 2021Vol.47 No.22
Clinical RoundupFree Researchers discover gene linked to bone cancer in children, identify potential novel therapy June 04, 2021Vol.47 No.22
Clinical RoundupFree ACCC report: COVID-19 took a heavy toll on cancer care staff and providers May 28, 2021Vol.47 No.21
Clinical RoundupFree UVA develops tools to advance genomics, cancer research May 28, 2021Vol.47 No.21
Clinical Roundup Imugene licenses CD19 oncolytic virus from City of Hope to turn CAR T therapy against solid tumors May 21, 2021Vol.47 No.20
Clinical Roundup Phase III KEYNOTE-522 trial meets dual primary endpoint of event-free survival in high-risk early-stage TNBC May 14, 2021Vol.47 No.19
